An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Kevin M. Kane
Advertisement
Kevin M. Kane, PhD, is CMC strategy director, Strategic Development Consulting, at PPD, part of Thermo Fisher Scientific.
Articles by Kevin M. Kane
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Advertisement
Latest Updated Articles
Exploring an Intelligent Drug Development ParadigmAugust 2nd 2023
- An Intelligent Drug Development Paradigm
August 2nd 2023
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
RRP Accelerated Approval: What VOCERYQ Means for Manufacturing Teams
5